Physician profile
Benjamin Michael Schaffer
NPI 1245238047
$2,887.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $143 · 2021: $617 · 2022: $1,465.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,207.00 | 2022 | |
| Stryker Corporation | $635.81 | 2019-2022 | |
| Melinta Therapeutics, LLC | $236.43 | 2019-2021 | |
| Dynasplint Systems INC. | $164.12 | 2021 | |
| Smith+Nephew, INC. | $143.69 | 2019-2022 | |
| Organogenesis INC. | $109.85 | 2019-2021 | |
| Horizon Therapeutics Plc | $73.27 | 2019-2021 | |
| Triad Life Sciences INC. | $44.62 | 2021 | |
| Medartis INC. | $41.33 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $40.98 | 2022 | |
| Abbvie INC. | $39.07 | 2022 | |
| Medtronic Vascular, INC. | $36.04 | 2019-2020 | |
| Tactile Systems Technology INC | $27.56 | 2019-2020 | |
| Zyla Life Sciences, INC. | $23.51 | 2019-2020 | |
| Bioventus LLC | $20.94 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $15.87 | 2021 | |
| Acumed LLC | $14.26 | 2021 | |
| Merck Sharp & Dohme LLC | $13.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.